Atypical Intraductal Proliferation in Patients With Grade Group 1-2 or No Invasive Cancer on Prostate Biopsy: An Institutional Experience
International Journal of Surgical Pathology · 11.11.2026
DOI: 10.1177/10668969261493464 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Surgical Pathology, online erschienen am 11.11.2026. Verfasst von Garrett Chan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of California San Francisco (UCSF), San Francisco, CA, USA. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The UCSF Urologic Outcomes Database has received funding from the Goldberg-Benioff Fund for Translational Cancer Biology..
Abstract (Originalsprache)
Objectives
Atypical intraductal proliferation (AIP) is an intraductal proliferation in which histologic features are more atypical than high-grade prostatic intraepithelial neoplasia but fall short of diagnostic criteria of intraductal carcinoma. We performed a retrospective review of patients with AIP and low-grade or no invasive cancer and correlated with follow-up and Decipher scores.
Methods
Prostate biopsies from 2016 to 2022 with AIP and no invasive carcinoma, Grade Group 1 (GG1, Gleason score 3 + 3 = 6) prostatic adenocarcinoma, or Grade Group 2 (GG2, Gleason score 3 + 4 = 7) prostatic adenocarcinoma were identified. Patients with concomitant intraductal carcinoma and/or ≥ GG3 were excluded. Decipher testing, PTEN staining, and subsequent biopsy/prostatectomy data were obtained from the medical record. Adverse features at prostatectomy were defined as ≥GG3, ≥pT3a, pN1, intraductal carcinoma, or Gleason pattern 5.
Results
There were 51 biopsies with AIP and no invasive cancer ( n = 5), GG1 ( n = 10), or GG2 ( n = 36) from 2016 to 2022. Of 18 patients who underwent subsequent biopsy, 6 (33%) had increase in Grade Group. Of 14 patients who underwent prostatectomy, 10 (71%) showed at least one adverse feature at prostatectomy. Twelve patients (10 GG2, 2 GG1) had Decipher testing. The median Decipher for the 10 GG2 biopsies was 0.53, corresponding to intermediate Decipher risk. The median Decipher for the 2 GG1 biopsies was 0.40, corresponding to low Decipher risk.
Conclusions
AIP in the absence of other high-risk features at biopsy may be a harbinger of subsequent adverse pathology on follow-up. AIP is an entity that may require more frequent active surveillance in the absence of other high-risk features.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, University of California San Francisco (UCSF), San Francisco, CA, USA.
- Helen Diller Family Comprehensive Cancer Center, University of California San Francisco (UCSF), San Francisco, CA, USA.
- Department of Urology, University of California San Francisco (UCSF), San Francisco, CA, USA.
- Department of Pathology, Stanford University, Stanford, CA, USA.
ORCID-Profile: Deepika Sirohi, Emily Chan, Nancy Y Greenland
Förderung
- The UCSF Urologic Outcomes Database has received funding from the Goldberg-Benioff Fund for Translational Cancer Biology.
Zitieren
APA
Chan, G., Sirohi, D., Ding, C. C., Cowan, J. E., Cooperberg, M. R., Carroll, P. R., Stohr, B. A., Chan, E., & Greenland, N. Y. (2026). Atypical Intraductal Proliferation in Patients With Grade Group 1-2 or No Invasive Cancer on Prostate Biopsy: An Institutional Experience. International Journal of Surgical Pathology. https://doi.org/10.1177/10668969261493464
Vancouver
Chan G, Sirohi D, Ding CC, Cowan JE, Cooperberg MR, Carroll PR, et al. Atypical Intraductal Proliferation in Patients With Grade Group 1-2 or No Invasive Cancer on Prostate Biopsy: An Institutional Experience. International Journal of Surgical Pathology. 2026. doi:10.1177/10668969261493464
BibTeX
@article{Chan2026,
author = {Chan, Garrett and Sirohi, Deepika and Ding, Chien-Kuang Cornelia and Cowan, Janet E and Cooperberg, Matthew R and Carroll, Peter R and Stohr, Bradley A and Chan, Emily and Greenland, Nancy Y},
title = {Atypical Intraductal Proliferation in Patients With Grade Group 1-2 or No Invasive Cancer on Prostate Biopsy: An Institutional Experience},
journal = {International Journal of Surgical Pathology},
year = {2026},
doi = {10.1177/10668969261493464}
}
EUVIMED